Literature DB >> 11593992

Time-controlled release pseudoephedrine tablets: bioavailability and in vitro/in vivo correlations.

M Halsas1, T Penttinen, P Veski, H Jürjenson, M Marvola.   

Abstract

In chronopharmacotherapy, circadian changes in disease symptoms are taken into account. Press-coated, time-controlled release tablets containing pseudoephedrine hydrochloride as a model drug have been formulated and the suitability of this highly soluble drug in relation to the new drug delivery system was evaluated. Hydroxypropylmethylcellulose was used in the coat of the tablet to adjust drug release. If such a formulation was administered in the evening it would have maximal effect in the early morning, and would be useful for the treatment of nocturnal symptoms. Two cross-over, single-dose bioavailability studies were carried out on eight healthy volunteers. A dissolution test method was developed to establish level A and level C in vitro/in vivo correlation for four formulations. With a low viscosity grade of polymer, peak concentrations were achieved after five hours. The drug was absorbed much more slowly from tablets containing a high viscosity grade polymer, with a plasma peak at ten hours. For further development of the drug delivery system described, a dissolution test method at pH 7.2 at a rotation speed of 150 min-1 is recommended on the basis of level A in vitro/in vivo correlation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11593992

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  2 in total

1.  Time- and pH-dependent colon-specific drug delivery for orally administered diclofenac sodium and 5-aminosalicylic acid.

Authors:  Gang Cheng; Feng An; Mei-Juan Zou; Jin Sun; Xiu-Hua Hao; Yun-Xia He
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

2.  In vitro controlled release of colon targeted mesalamine from compritol ATO 888 based matrix tablets using factorial design.

Authors:  J K Patel; N V Patel; S H Shah
Journal:  Res Pharm Sci       Date:  2009-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.